SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-008948
Filing Date
2022-02-11
Accepted
2022-02-11 17:33:21
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 5517
  Complete submission text file 0001209191-22-008948.txt   7126
Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address
Scopa James Paul (Reporting) CIK: 0001356950 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-40794 | Film No.: 22623031

Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Issuer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations